PubMed COVID-19 Clinical Care

Airway epithelial cell identity and plasticity are constrained by Sox2 during lung homeostasis, tissue regeneration, and in human disease

Friday, January 05, 2024 - 4:00 AM

Maintenance of the cellular boundary between airway and alveolar compartments during homeostasis and after injury is essential to prohibit pathological plasticity which can reduce respiratory function. Lung injury and disease can induce either

A retrospective, observational study analysing effectiveness of sotrovimab in preventing hospitalisation and deaths from COVID-19 and which subgroup of high-risk patients are more likely to benefit due to the absence of COVID-19 spike antibody post vac...

Friday, January 05, 2024 - 4:00 AM

No abstract

A retrospective, observational study analysing effectiveness of sotrovimab in preventing hospitalisation and deaths from COVID-19 and which subgroup of high-risk patients are more likely to benefit due to the absence of COVID-19 spike antibody post vac...

Friday, January 05, 2024 - 4:00 AM

No abstract

A retrospective, observational study analysing effectiveness of sotrovimab in preventing hospitalisation and deaths from COVID-19 and which subgroup of high-risk patients are more likely to benefit due to the absence of COVID-19 spike antibody post vac...

Friday, January 05, 2024 - 4:00 AM

No abstract

A retrospective, observational study analysing effectiveness of sotrovimab in preventing hospitalisation and deaths from COVID-19 and which subgroup of high-risk patients are more likely to benefit due to the absence of COVID-19 spike antibody post vac...

Friday, January 05, 2024 - 4:00 AM

No abstract

A retrospective, observational study analysing effectiveness of sotrovimab in preventing hospitalisation and deaths from COVID-19 and which subgroup of high-risk patients are more likely to benefit due to the absence of COVID-19 spike antibody post vac...

Friday, January 05, 2024 - 4:00 AM

No abstract

A retrospective, observational study analysing effectiveness of sotrovimab in preventing hospitalisation and deaths from COVID-19 and which subgroup of high-risk patients are more likely to benefit due to the absence of COVID-19 spike antibody post vac...

Friday, January 05, 2024 - 4:00 AM

No abstract

A single-armed proof-of-concept study of Lymfit: A personalized, virtual exercise intervention to improve health outcomes in lymphoma survivors in the pandemic

Friday, January 05, 2024 - 4:00 AM

BACKGROUND AND OBJECTIVE: Treatments of lymphoma can lead to reduced physical functioning, cancer-related fatigue, depression, anxiety, and insomnia. These side effects can negatively impact the cancer survivor's quality of life. Mounting evidence

Artificial Intelligence in battling infectious diseases: A transformative role

Friday, January 05, 2024 - 4:00 AM

It is widely acknowledged that infectious diseases have wrought immense havoc on human society, being regarded as adversaries from which humanity cannot elude. In recent years, the advancement of Artificial Intelligence (AI) technology has ushered in

A rare case of opsoclonus myoclonus syndrome following COVID-19 illness

Friday, January 05, 2024 - 4:00 AM

No abstract